March 2, 2026 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 139,500 shares of Novavax, Inc. at $9.09 per share, a transaction worth $1.27M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
One quarter of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.